Clinical Trial Update: Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial update on flexible-dose, long-term safety of Lu AF35700 in adults with schizophrenia; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Lu AF35700 (Lu AF35700)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2020-10-26